Opportunity Information: Apply for CDC RFA GH13 130204CONT16
Apply for CDC RFA GH13 130204CONT16
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Support for Activities to Eradicate Polio, Accelerate control of measles and rubella" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185 Immunization Research, Demonstration, Public Information and EducationTraining and Clinical Skills Improvement Projects.
- This funding opportunity was created on Jul 31, 2015 and posted on Jul 31, 2015.
- Applicants must submit their applications by Sep 25, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under GH13 1302 Support for Activities to Eradicate Polio, Accelerate control of measles and rubella
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Support for Activities to Eradicate Polio, Accelerate control of measles and rubella" is a Centers for Disease Control and Prevention (CDC) continuation funding announcement designed to sustain ongoing public health work focused on three closely linked immunization priorities: eliminating polio, speeding up measles control, and strengthening rubella control efforts. The opportunity was issued as a cooperative agreement, which typically means the CDC expects to have substantial involvement with recipients during the project period, such as providing technical guidance, coordinating activities, or aligning work with broader global or regional disease eradication and elimination strategies. The activity category is health, and the CFDA listing associated with it is 93.185, which covers immunization research and demonstration activities, public information and education, and training and clinical skills improvement projects.
This particular announcement is not an open competition. It is explicitly a continuation award intended only for organizations that were already funded under the earlier award "GH13-1302 Support for Activities to Eradicate Polio, Accelerate control of measles and rubella." In practical terms, that means new applicants who were not part of the original GH13-1302 award would not be eligible to apply under this notice. The "Eligible Applicants" field is broadly labeled as "Others," but the eligibility restriction clarifies that only existing grantees from the prior funding cycle can receive these continuation funds. There is also no cost sharing or matching requirement, so recipients are not required to contribute non-federal funds as a condition of receiving the award.
The administrative timeline shows the opportunity was posted on July 31, 2015, with an original and current closing date of September 25, 2015, and it was archived on October 25, 2015. The listing indicates an expected number of awards of 50, suggesting a sizable portfolio of continuing projects or country and partner awards supporting immunization systems and disease control activities at scale. The funding fields in the summary (estimated total funding, award ceiling, award floor) are shown as zero, which often happens in continuation notices or summary extracts where exact dollar amounts are not displayed in the public listing, may vary by recipient, or are handled through internal continuation processes rather than a standard competitive award structure.
In terms of what the work is meant to support, the title and program alignment point to activities that help maintain and intensify immunization and surveillance efforts. For polio eradication, that commonly includes strengthening acute flaccid paralysis surveillance, improving laboratory networks, supporting supplementary immunization activities, maintaining high routine immunization coverage, and responding rapidly to outbreaks or detection events. For measles and rubella control, typical supported areas include case-based surveillance, outbreak preparedness and response, improving the quality and reach of measles-containing and rubella-containing vaccine delivery, addressing immunity gaps, and enhancing data quality and use for immunization planning. Because this is a cooperative agreement, the CDC would generally work alongside recipients to ensure these activities are technically sound, aligned with global eradication and elimination goals, and coordinated with other partners operating in immunization and disease control.
The funding opportunity number is CDC-RFA-GH13-130204CONT16, which signals it is a continuation (the "CONT" designation) tied to the original GH13-1302 program. Applicants or funded partners needing help accessing the full announcement were directed to the CDC Procurement and Grants Office, with contact options including phone (770-488-2700) and email (pgotim@cdc.gov).
Frequently Asked Questions (FAQs)
1) What is the title of this grant opportunity?
The opportunity is titled "Support for Activities to Eradicate Polio, Accelerate control of measles and rubella."
2) Which federal agency is offering this funding?
This is a Centers for Disease Control and Prevention (CDC) funding announcement.
3) What type of funding mechanism is this?
It is offered as a cooperative agreement, which generally means CDC expects substantial involvement with recipients during the project period (for example, providing technical guidance, coordinating activities, or aligning work with broader strategies).
4) Is this an open competition?
No. This is explicitly a continuation funding announcement and is not open to new applicants.
5) Who is eligible to receive this continuation funding?
Only organizations that were already funded under the earlier award "GH13-1302 Support for Activities to Eradicate Polio, Accelerate control of measles and rubella" are eligible for this continuation award.
6) The listing says "Eligible Applicants: Others." Does that mean anyone can apply?
No. Even though the field is broadly labeled as "Others," the eligibility restriction clarifies that only existing grantees from the prior GH13-1302 award can receive these continuation funds.
7) What are the main public health priorities supported by this announcement?
The work is focused on three closely linked immunization priorities: eliminating polio, accelerating measles control, and strengthening rubella control efforts.
8) What kinds of polio eradication activities are typically supported under this type of program?
Activities commonly include strengthening acute flaccid paralysis (AFP) surveillance, improving laboratory networks, supporting supplementary immunization activities, maintaining high routine immunization coverage, and responding rapidly to outbreaks or detection events.
9) What kinds of measles and rubella control activities are typically supported?
Typical areas include case-based surveillance, outbreak preparedness and response, improving the quality and reach of measles-containing and rubella-containing vaccine delivery, addressing immunity gaps, and improving data quality and use for immunization planning.
10) What is the activity category for this opportunity?
The activity category is health.
11) What CFDA listing is associated with this opportunity, and what does it cover?
The CFDA listing is 93.185. It covers immunization research and demonstration activities, public information and education, and training and clinical skills improvement projects.
12) Does this opportunity require cost sharing or matching funds?
No. There is no cost sharing or matching requirement indicated for this continuation award.
13) When was this opportunity posted?
The opportunity was posted on July 31, 2015.
14) What was the closing date for this announcement?
The original and current closing date listed is September 25, 2015.
15) Has the opportunity been archived?
Yes. It was archived on October 25, 2015.
16) How many awards were expected under this continuation announcement?
The listing indicates an expected number of awards of 50.
17) Why do the funding fields show an estimated total funding amount, ceiling, and floor of $0?
The summary shows those fields as zero, which can occur in continuation notices or summary extracts when exact dollar amounts are not displayed in the public listing, may vary by recipient, or are handled through internal continuation processes rather than a standard competitive award structure.
18) What is the funding opportunity number?
The funding opportunity number is CDC-RFA-GH13-130204CONT16, indicating it is a continuation ("CONT") tied to the original GH13-1302 program.
19) What does CDC involvement typically look like in a cooperative agreement for this type of work?
Because it is a cooperative agreement, CDC would generally work alongside recipients to help ensure activities are technically sound, aligned with global eradication and elimination goals, and coordinated with other partners working in immunization and disease control.
20) Who can be contacted for help accessing the full announcement or for administrative questions?
Applicants or funded partners needing help were directed to the CDC Procurement and Grants Office. Contact options listed are phone 770-488-2700 and email pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Field Ecology and Technical Support for Long term Monitoring in National Parks of the Southern Colorado Plateau Network
Previous opportunity: ational Park Service A Cultural Landscape Inventory, National Register Nomination Form and Curation and Archiving of Archeological Materials and Records from Old Salt Trail Archeological Surveys.
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 130204CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 130204CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Emerging Infections ProgramNational Center for Emerging and Zoonotic Infectious Diseases Apply for CDC RFA CK12 120205CONT16 Funding Number: CDC RFA CK12 120205CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Poliomyelitis Eradication Initiative and Expanded Programme On Immunization Apply for CDC RFA GH13 130104CONT16 Funding Number: CDC RFA GH13 130104CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Enhancing Public Health Surveillance of Autism Spectrum Disorders and Other Developmental Disabilities through the Autism and Developmental Disabilities Monitoring (ADDM) Network Apply for CDC RFA DD15 150102CONT16 Funding Number: CDC RFA DD15 150102CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National HIV Surveillance System (NHSS) Apply for CDC RFA PS13 13020401SUPP16 Funding Number: CDC RFA PS13 13020401SUPP16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $120,000 |
| AHRQ Grants for Health Services Research Dissertation Program (R36) Apply for PA 15 318 Funding Number: PA 15 318 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Tuskegee University Apology Commemoration Activities Apply for CDC RFA PS15 150402CONT16 Funding Number: CDC RFA PS15 150402CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research on Chronic Disease Prevention (U54) Apply for RFA MD 15 014 Funding Number: RFA MD 15 014 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| U.S. India Collaborative Vision Research Program (R01) Apply for PAR 15 320 Funding Number: PAR 15 320 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Pilot Services Research Grants Not Involving Interventions (R34) Apply for PAR 15 323 Funding Number: PAR 15 323 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Special Diabetes Program for Indians Community Directed Program Apply for HHS 2016 IHS SDPI 0001 Funding Number: HHS 2016 IHS SDPI 0001 Agency: Indian Health Service Category: Health Funding Amount: $6,500,000 |
| Alzheimers Disease Core Centers (P30) Apply for RFA AG 16 018 Funding Number: RFA AG 16 018 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Apply for RFA PS 16 001 Funding Number: RFA PS 16 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Building Genomic Sequencing Capacity in Kenya Apply for CDC RFA GH15 1636 Funding Number: CDC RFA GH15 1636 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Ethical, Legal and Policy Issues in HIV Research with Key Populations (R21) Apply for PAR 15 327 Funding Number: PAR 15 327 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Oral HIVacc Oral Mucosal Immunization Approaches for HIV Prevention (R01) Apply for RFA DE 16 006 Funding Number: RFA DE 16 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ethical, Legal and Policy Issues in HIV Research with Key Populations (R01) Apply for PAR 15 328 Funding Number: PAR 15 328 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A National Coalition to Enhance STD/HIV Prevention through Promotion of a Holistic Approach to Health and Wellness Apply for CDC RFA PS11 111205CONT15 Funding Number: CDC RFA PS11 111205CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Short term Measurements of Improved Physical and Molecular Resilience in Pre clinical Models (R01) Apply for RFA AG 16 006 Funding Number: RFA AG 16 006 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| USAID/GHANA PEOPLE FOR HEALTH Apply for RFA 641 15 000009 Funding Number: RFA 641 15 000009 Agency: Ghana USAID Accra Category: Health Funding Amount: $3,710,000 |
| Centers of Research Translation (P50) Apply for RFA AR 16 001 Funding Number: RFA AR 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 130204CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.